+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatology OTC Medications Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Route of Administration, Indication and Distribution Channel

  • PDF Icon

    Report

  • 279 Pages
  • March 2022
  • Region: Global
  • The Insight Partners
  • ID: 5576238

Dermatology OTC Medications Market is expected to reach US$ 21,313.40 Million by 2028

Dermatology OTC Medications Market for Acne Segment to Grow Significantly During 2021-2028



According to the latest research study on “Dermatology OTC Medications Market Forecast to 2028 - COVID-19 Impact Analysis - by Product Type, Route of Administration, Indication, and Distribution Channel,” the market is expected to grow from US$ 15,456.63 million in 2021 to US$ 21,313.40 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028. The report highlights trends prevailing in the market and the factors governing the dermatology OTC medications market growth.

Dermatology over-the-counter (OTC) drugs are sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. These medications are widely used in skin diseases, such as dermatitis, acne, psoriasis, skin bleaching, fungal infections, and warts.

Based on indication, the global dermatology OTC medications market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment held the largest share of the market in 2021; it is estimated to register the highest CAGR during the forecast period. This high share of acne segment is due to high prevalence of acne across the globe. Acne vulgaris is becoming more prevalent in every country. Dermatology OTC medications are widely used in the treatment of acne. Understanding the characteristics of acne vulgaris burden is critical for developing effective and targeted acne control therapies. According to the Global Burden of Disease Study 2019, 117.4 million incident cases of acne vulgaris, 231.2 million prevalent cases, and 5 million disability-adjusted life years (DALYs) were reported worldwide, representing a 48% increase since 1990. Thus, the high prevalence of skin diseases supports the market's growth during the forecast period. Acne affected 5.6 million Canadians, or ~20% of the population, according to the Canadian Dermatology Association in 2021. Similarly, ~80% of acne patients are aged between 12 and 24. Acne affects ~90% of teenagers and 20-30% of adults aged from 20 to 40. Similarly, as per a study published in the journal Actas Dermo-Sifiliográficas in 2019, the prevalence of psoriasis in France was 5.2% of the entire French population. Moreover, according to 2020 US census data, ~7.55 million US individuals are suffering from psoriasis. The prevalence of psoriasis was similar in men and women, with 3.2% in women and 2.8% in men.

Bausch Health Companies Inc.; Perrigo Company plc; Bayer AG; Viatris Inc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S.; GlaxoSmithKline plc.; Galderma; Dr. Reddy's Laboratories; and Acella Pharmaceuticals, LLC are among the leading companies operating in the market.

The report segments the dermatology OTC medications market as follows:


The market is segmented into product type, route of administration, indication, and distribution channel. Based on product type, the global market is segmented into tablets and capsules; gels; creams and ointments; and others. The creams and ointments segment held the largest share of the market in 2021. However, the tablets and capsules segment is estimated to register the highest CAGR during the forecast period. Based on route of administration, the market is bifurcated into topical and oral. The topical segment held the largest share of the market in 2021; however, the oral segment is estimated to register the highest CAGR during the forecast period.

Based on indication, the market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment held the largest share of the market in 2021; however, the same segment is estimated to register the highest CAGR during the forecast period.

Based on distribution channel, the market is bifurcated into online distribution and offline distribution. The topical segment held the largest share of the market in 2021; however, the oral segment is estimated to register the highest CAGR during the forecast period. Furthermore, offline distribution is sub-segment into retail & hospital pharmacies and super & hyper markets. The retail & hospital pharmacies segment held the largest share of the market in 2021.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global dermatology OTC medications market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the global dermatology OTC medications market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Frequently Asked Questions about the Global Dermatology OTC Medications Market

What is the estimated value of the Global Dermatology OTC Medications Market?

The Global Dermatology OTC Medications Market was estimated to be valued at $15456.6 Million in 2021.

What is the growth rate of the Global Dermatology OTC Medications Market?

The growth rate of the Global Dermatology OTC Medications Market is 4.7%, with an estimated value of $21313.4 Million by 2028.

What is the forecasted size of the Global Dermatology OTC Medications Market?

The Global Dermatology OTC Medications Market is estimated to be worth $21313.4 Million by 2028.

Who are the key companies in the Global Dermatology OTC Medications Market?

Key companies in the Global Dermatology OTC Medications Market include Bausch Health Companies Inc., Perrig, Company plc, Bayer AG, Viatris Inc., Johnson and Johnson Services, Inc., Le, Pharma A/S and Galderma.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Dermatology OTC Medications Market - By Product Type
1.3.2 Global Dermatology OTC Medications Market - By Route of Administration
1.3.3 Global Dermatology OTC Medications Market - By Indication
1.3.4 Global Dermatology OTC Medications Market - By Distribution Channel
1.3.5 Global Dermatology OTC Medications Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Dermatology OTC Medications Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion
5. Dermatology OTC Medications Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 High Prevalence of Skin Problems
5.1.2 Rising Income of Middle-Class Population
5.2 Market Restraints
5.2.1 Inappropriate Use of OTC Medications
5.3 Market Opportunities
5.3.1 Growing OTC Market
5.4 Future Trends
5.4.1 Transition from Rx to OTC
5.5 Impact Analysis of Drivers and Restraints
6. Dermatology OTC Medications Market- Global Analysis
6.1 Global Dermatology OTC Medications Market Revenue Forecast and Analysis
6.2 Global Dermatology OTC Medications Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Dermatology OTC Medications Market Analysis - By Product Type
7.1 Overview
7.2 Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)
7.3 Tablets and Capsules
7.3.1 Overview
7.3.2 Tablets and Capsules Market Revenue and Forecast to 2028 (US$ million)
7.4 Gels
7.4.1 Overview
7.4.2 Gels Market Revenue and Forecast to 2028 (US$ million)
7.5 Creams and Ointments
7.5.1 Overview
7.5.2 Creams and Ointments Market Revenue and Forecast to 2028 (US$ million)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ million)
8. Dermatology OTC medications Market Analysis - By Route of Administration
8.1 Overview
8.2 Dermatology OTC Medications Market Share, by Route of Administration, 2021 and 2028 (%)
8.3 Topical
8.3.1 Overview
8.3.2 Topical: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Oral
8.4.1 Overview
8.4.2 Oral: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9. Dermatology OTC Medications Market Analysis - By Indication
9.1 Overview
9.2 Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)
9.3 Dermatitis
9.3.1 Overview
9.3.2 Dermatitis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.3.3 Atopic Dermatitis
9.3.3.1 Overview
9.3.3.2 Atopic Dermatitis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.3.4 Contact Dermatitis
9.3.4.1 Overview
9.3.4.2 Contact Dermatitis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.3.5 Others
9.3.5.1 Overview
9.3.5.2 Others: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Acne
9.4.1 Overview
9.4.2 Acne: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.4.3 Non-Inflammatory Acne
9.4.3.1 Overview
9.4.3.2 Non-Inflammatory Acne: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.4.4 Inflammatory Acne
9.4.4.1 Overview
9.4.4.2 Inflammatory Acne: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Psoriasis
9.5.1 Overview
9.5.2 Psoriasis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.5.3 Plaque Psoriasis
9.5.3.1 Overview
9.5.3.2 Plaque Psoriasis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.5.4 Guttate Psoriasis
9.5.4.1 Overview
9.5.4.2 Guttate Psoriasis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.5.5 Others
9.5.5.1 Overview
9.5.5.2 Others: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.6 Skin Bleaching
9.6.1 Overview
9.6.2 Skin Bleaching: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.7 Fungal Disease
9.7.1 Overview
9.7.2 Fungal Disease: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.7.3 Athlete's Foot
9.7.3.1 Overview
9.7.3.2 Athlete's Foot: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.7.4 Ringworm
9.7.4.1 Overview
9.7.4.2 Ringworm: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.7.5 Fungal Nail Infections
9.7.5.1 Overview
9.7.5.2 Fungal Nail Infections: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.7.6 Others
9.7.6.1 Overview
9.7.6.2 Others: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.8 Warts
9.8.1 Overview
9.8.2 Warts: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.8.3 Common Warts
9.8.3.1 Overview
9.8.3.2 Common Warts: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.8.4 Flat Warts
9.8.4.1 Overview
9.8.4.2 Flat Warts: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.8.5 Others
9.8.5.1 Overview
9.8.5.2 Others: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
10. Dermatology OTC medications Market Analysis - By Distribution Channel
10.1 Overview
10.2 Dermatology OTC Medications Market Share, by Distribution Channel, 2021 and 2028 (%)
10.3 Online Distribution
10.3.1 Overview
10.3.2 Online Distribution: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
10.4 Offline Distribution
10.4.1 Overview
10.4.2 Offline Distribution: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
10.4.3 Retail and Hospital Pharmacies
10.4.3.1 Overview
10.4.3.2 Retail and Hospital Pharmacies: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
10.4.4 Super and Hyper Markets
10.4.4.1 Overview
10.4.4.2 Super and Hyper Markets: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
11. Dermatology OTC Medications Market Revenue and Forecasts to 2028 - Geographical Analysis
11.1 North America Dermatology OTC Medications Market Revenue and Forecasts To
11.1.1 Overview
11.1.2 North America: Dermatology OTC Medications - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.1.4 North America: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.1.5 North America: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.1.5.1 North America: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.1.5.2 North America: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.1.5.3 North America: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.1.5.4 North America: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.1.5.5 North America: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.1.6 North America: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.6.1 North America: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.1.7 North America Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)
11.1.8 US: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.1 Overview
11.1.8.2 US: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.3 US: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.1.8.4 US: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.1.8.5 US: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.1.8.5.1 US: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.1.8.5.2 US: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.1.8.5.3 US: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.1.8.5.4 US: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.1.8.5.5 US: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.1.8.6 US: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.8.6.1 US: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.1.9 Canada: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.1.9.1 Overview
11.1.9.2 Canada: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.1.9.3 Canada: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.1.9.4 Canada: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.1.9.5 Canada: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.1.9.5.1 Canada: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.1.9.5.2 Canada: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.1.9.5.3 Canada: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.1.9.5.4 Canada: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.1.9.5.5 Canada: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.1.9.6 Canada: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.9.6.1 Canada: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.1.10 Mexico: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.1.10.1 Overview
11.1.10.2 Mexico: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.1.10.3 Mexico: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.1.10.4 Mexico: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.1.10.5 Mexico: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.1.10.5.1 Mexico: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.1.10.5.2 Mexico: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.1.10.5.3 Mexico: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.1.10.5.4 Mexico: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.1.10.5.5 Mexico: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.1.10.6 Mexico: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.10.6.1 Mexico: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.2 Europe Dermatology OTC Medications Market Revenue and Forecasts To
11.2.1 Overview
11.2.2 Europe: Dermatology OTC Medications - Revenue and Forecast to 2028 (USD Million)
11.2.3 Europe: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.2.4 Europe: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.2.5 Europe: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.2.5.1 Europe: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.2.5.2 Europe: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.2.5.3 Europe: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.2.5.4 Europe: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.2.5.5 Europe: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.2.6 Europe: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.2.6.1 Europe: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.2.7 Europe: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)
11.2.8 Germany: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.1 Overview
11.2.8.2 Germany: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.3 Germany: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.2.8.4 Germany: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.2.8.5 Germany: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.2.8.5.1 Germany: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.2.8.5.2 Germany: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.2.8.5.3 Germany: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.2.8.5.4 Germany: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.2.8.5.5 Germany: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.2.8.6 Germany: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.2.8.6.1 Germany: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.2.9 France: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.9.1 Overview
11.2.9.2 France: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.9.3 France: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.2.9.4 France: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.2.9.5 France: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.2.9.5.1 France: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.2.9.5.2 France: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.2.9.5.3 France: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.2.9.5.4 France: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.2.9.5.5 France: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.2.9.6 France: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.2.9.6.1 France: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.2.10 UK: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.10.1 Overview
11.2.10.2 UK: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.10.3 UK: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.2.10.4 UK: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.2.10.5 UK: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.2.10.5.1 UK: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.2.10.5.2 UK: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.2.10.5.3 UK: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.2.10.5.4 UK: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.2.10.5.5 UK: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.2.10.6 UK: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.2.10.6.1 UK: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.2.11 Italy: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.11.1 Overview
11.2.11.2 Italy: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.11.3 Italy: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.2.11.4 Italy: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.2.11.5 Italy: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.2.11.5.1 Italy: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.2.11.5.2 Italy: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.2.11.5.3 Italy: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.2.11.5.4 Italy: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.2.11.5.5 Italy: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.2.11.6 Italy: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.2.11.6.1 Italy: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.2.12 Spain: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.12.1 Overview
11.2.12.2 Spain: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.12.3 Spain: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.2.12.4 Spain: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.2.12.5 Spain: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.2.12.5.1 Spain: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.2.12.5.2 Spain: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.2.12.5.3 Spain: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.2.12.5.4 Spain: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.2.12.5.5 Spain: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.2.12.6 Spain: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.2.12.6.1 Spain: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.2.13 Rest of Europe: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.13.1 Overview
11.2.13.2 Rest of Europe: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.2.13.3 Rest of Europe: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.2.13.4 Rest of Europe: Dermatology OTC Medications Market, by Route of Administration, 2019-2028 (USD Million)
11.2.13.5 Rest of Europe: Dermatology OTC Medications Market, by Indication, 2019-2028 (USD Million)
11.2.13.5.1 Rest of Europe: Dermatology OTC Medications Market, by Dermatitis, 2019-2028 (USD Million)
11.2.13.5.2 Rest of Europe: Dermatology OTC Medications Market, by Acne, 2019-2028 (USD Million)
11.2.13.5.3 Rest of Europe: Dermatology OTC Medications Market, by Psoriasis, 2019-2028 (USD Million)
11.2.13.5.4 Rest of Europe: Dermatology OTC Medications Market, by Fungal Disease, 2019-2028 (USD Million)
11.2.13.5.5 Rest of Europe: Dermatology OTC Medications Market, by Warts, 2019-2028 (USD Million)
11.2.13.6 Rest of Europe: Dermatology OTC Medications Market, by Distribution Channel, 2019-2028 (USD Million)
11.2.13.6.1 Rest of Europe: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.3 Asia Pacific: Dermatology OTC Medications Market
11.3.1 Overview
11.3.2 Asia Pacific: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.3.4 Asia Pacific: Dermatology OTC Medications Market, By Route of Administration,2019-2028 (USD Million)
11.3.5 Asia Pacific: Dermatology OTC Medications Market, By Indication, 2019-2028 (USD Million)
11.3.5.1 Asia Pacific: Dermatology OTC Medications Market, by Acne Indication, 2019-2028 (USD Million)
11.3.5.2 Asia Pacific: Dermatology OTC Medications Market, by Dermatitis Indication, 2019-2028 (USD Million)
11.3.5.3 Asia Pacific: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019-2028 (USD Million)
11.3.5.4 Asia Pacific: Dermatology OTC Medications Market, by Psoriasis Indication, 2019-2028 (USD Million)
11.3.5.5 Asia Pacific: Dermatology OTC Medications Market, by Warts Indication, 2019-2028 (USD Million)
11.3.6 Asia Pacific: Dermatology OTC Medications Market, By Distribution Channel, 2019-2028 (USD Million)
11.3.6.1 Asia Pacific: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.3.7 Asia Pacific: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)
11.3.8 China: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.1 China: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.2 China: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.3.8.3 China: Dermatology OTC Medications Market, By Route of Administration,2019-2028 (USD Million)
11.3.8.4 China: Dermatology OTC Medications Market, By Indication, 2019-2028 (USD Million)
11.3.8.4.1 China: Dermatology OTC Medications Market, by Acne Indication, 2019-2028 (USD Million)
11.3.8.4.2 China: Dermatology OTC Medications Market, by Dermatitis Indication, 2019-2028 (USD Million)
11.3.8.4.3 China: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019-2028 (USD Million)
11.3.8.4.4 China: Dermatology OTC Medications Market, by Psoriasis Indication, 2019-2028 (USD Million)
11.3.8.4.5 China: Dermatology OTC Medications Market, by Warts Indication, 2019-2028 (USD Million)
11.3.8.5 China: Dermatology OTC Medications Market, By Distribution Channel, 2019-2028 (USD Million)
11.3.8.5.1 China: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.3.9 Japan: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.9.1 Japan: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.9.2 Japan: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.3.9.3 Japan: Dermatology OTC Medications Market, By Route of Administration,2019-2028 (USD Million)
11.3.9.4 Japan: Dermatology OTC Medications Market, By Indication, 2019-2028 (USD Million)
11.3.9.4.1 Japan: Dermatology OTC Medications Market, by Acne Indication, 2019-2028 (USD Million)
11.3.9.4.2 Japan: Dermatology OTC Medications Market, by Dermatitis Indication, 2019-2028 (USD Million)
11.3.9.4.3 Japan: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019-2028 (USD Million)
11.3.9.4.4 Japan: Dermatology OTC Medications Market, by Psoriasis Indication, 2019-2028 (USD Million)
11.3.9.4.5 Japan: Dermatology OTC Medications Market, by Warts Indication, 2019-2028 (USD Million)
11.3.9.5 Japan: Dermatology OTC Medications Market, By Distribution Channel, 2019-2028 (USD Million)
11.3.9.5.1 Japan: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.3.10 India: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.10.1 India: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.10.2 India: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.3.10.3 India: Dermatology OTC Medications Market, By Route of Administration,2019-2028 (USD Million)
11.3.10.3.1 India: Dermatology OTC Medications Market, By Indication, 2019-2028 (USD Million)
11.3.10.3.2 India: Dermatology OTC Medications Market, by Acne Indication, 2019-2028 (USD Million)
11.3.10.3.3 India: Dermatology OTC Medications Market, by Dermatitis Indication, 2019-2028 (USD Million)
11.3.10.3.4 India: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019-2028 (USD Million)
11.3.10.3.5 India: Dermatology OTC Medications Market, by Psoriasis Indication, 2019-2028 (USD Million)
11.3.10.3.6 India: Dermatology OTC Medications Market, by Warts Indication, 2019-2028 (USD Million)
11.3.10.4 India: Dermatology OTC Medications Market, By Distribution Channel, 2019-2028 (USD Million)
11.3.10.4.1 India: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.3.11 Australia: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.11.1 Australia: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.11.2 Australia: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.3.11.3 Australia: Dermatology OTC Medications Market, By Route of Administration,2019-2028 (USD Million)
11.3.11.4 Australia: Dermatology OTC Medications Market, By Indication, 2019-2028 (USD Million)
11.3.11.4.1 Australia: Dermatology OTC Medications Market, by Acne Indication, 2019-2028 (USD Million)
11.3.11.4.2 Australia: Dermatology OTC Medications Market, by Dermatitis Indication, 2019-2028 (USD Million)
11.3.11.4.3 Australia: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019-2028 (USD Million)
11.3.11.4.4 Australia: Dermatology OTC Medications Market, by Psoriasis Indication, 2019-2028 (USD Million)
11.3.11.4.5 Australia: Dermatology OTC Medications Market, by Warts Indication, 2019-2028 (USD Million)
11.3.11.5 Australia: Dermatology OTC Medications Market, By Distribution Channel, 2019-2028 (USD Million)
11.3.11.5.1 Australia: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.3.12 South Korea: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.12.1 South Korea: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.12.2 South Korea: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.3.12.3 South Korea: Dermatology OTC Medications Market, By Route of Administration,2019-2028 (USD Million)
11.3.12.4 South Korea: Dermatology OTC Medications Market, By Indication, 2019-2028 (USD Million)
11.3.12.4.1 South Korea: Dermatology OTC Medications Market, by Acne Indication, 2019-2028 (USD Million)
11.3.12.4.2 South Korea: Dermatology OTC Medications Market, by Dermatitis Indication, 2019-2028 (USD Million)
11.3.12.4.3 South Korea: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019-2028 (USD Million)
11.3.12.4.4 South Korea: Dermatology OTC Medications Market, by Psoriasis Indication, 2019-2028 (USD Million)
11.3.12.4.5 South Korea: Dermatology OTC Medications Market, by Warts Indication, 2019-2028 (USD Million)
11.3.12.5 South Korea: Dermatology OTC Medications Market, By Distribution Channel, 2019-2028 (USD Million)
11.3.12.5.1 South Korea: Dermatology OTC Medications Market, by Offline Distribution, 2019-2028 (USD Million)
11.3.13 Rest of Asia Pacific: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.13.1 Rest of Asia Pacific: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
11.3.13.2 Rest of Asia Pacific: Dermatology OTC Medications Market, by Product Type, 2019-2028 (USD Million)
11.3.13.3 Rest of Asia Pacific: Dermatology OTC Medications Market, By Route of Administration,2019-2028 (USD Million)
11.3.13.4 Rest of Asia Pacific: Dermatology OTC Medications Market, By Indication, 2019-2028 (USD Million)
11.3.13.4.1 Rest of Asia Pacific: Dermatology OTC Medications Market, by Acne Indication, 2019-2028 (USD Million)
11.3.13.4.2 Rest of Asia Pacific: Dermatology OTC Medications Market, by Dermatitis Indication, 2019-2028 (USD Million)
11.3.13.4.3 Rest of Asia Pacific: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019-2028 (USD Million)
List of Tables
Table 1. North America: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 2. North America: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 3. North America: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 4. North America: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 5. North America: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 6. North America: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 7. North America: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 8. North America: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 9. North America: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 10. North America: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 11. US: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 12. US: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 13. US: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 14. US: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 15. US: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 16. US: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 17. US: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 18. US: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 19. US: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 20. US: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 21. Canada: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 22. Canada: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 23. Canada: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 24. Canada: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 25. Canada: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 26. Canada: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 27. Canada: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 28. Canada: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 29. Canada: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 30. Canada: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 31. Mexico: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 32. Mexico: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 33. Mexico: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 34. Mexico: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 35. Mexico: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 36. Mexico: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 37. Mexico: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 38. Mexico: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 39. Mexico: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 40. Mexico: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 41. Europe: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 42. Europe: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 43. Europe: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 44. Europe: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 45. Europe: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 46. Europe: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 47. Europe: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 48. Europe: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 49. Europe: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 50. Europe: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 51. Germany: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 52. Germany: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 53. Germany: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 54. Germany: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 55. Germany: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 56. Germany: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 57. Germany: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 58. Germany: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 59. Germany: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 60. Germany: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 61. France: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 62. France: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 63. France: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 64. France: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 65. France: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 66. France: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 67. France: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 68. France: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 69. France: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 70. France: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 71. UK: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 72. UK: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 73. UK: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 74. UK: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 75. UK: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 76. UK: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 77. UK: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 78. UK: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 79. UK: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 80. UK: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 81. Italy: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 82. Italy: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 83. Italy: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 84. Italy: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 85. Italy: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 86. Italy: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 87. Italy: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 88. Italy: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 89. Italy: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 90. Italy: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 91. Spain: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 92. Spain: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 93. Spain: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 94. Spain: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 95. Spain: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 96. Spain: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 97. Spain: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 98. Spain: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 99. Spain: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 100. Spain: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 101. Rest of Europe: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 102. Rest of Europe: Dermatology OTC Medications Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 103. Rest of Europe: Dermatology OTC Medications Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 104. Rest of Europe: Dermatology OTC Medications Market, by Dermatitis - Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of Europe: Dermatology OTC Medications Market, by Acne - Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of Europe: Dermatology OTC Medications Market, by Psoriasis - Revenue and Forecast to 2028 (USD Million)
Table 107. Rest of Europe: Dermatology OTC Medications Market, by Fungal Disease - Revenue and Forecast to 2028 (USD Million)
Table 108. Rest of Europe: Dermatology OTC Medications Market, by Warts - Revenue and Forecast to 2028 (USD Million)
Table 109. Rest of Europe: Dermatology OTC Medications Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 110. Rest of Europe: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 111. Asia Pacific: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 112. Asia Pacific: Dermatology OTC Medications Market, By Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 113. Asia Pacific: Dermatology OTC Medications Market, By Indication - Revenue and Forecast to 2028 (USD Million)
Table 114. Asia Pacific: Dermatology OTC Medications Market, by Acne Indication - Revenue and Forecast to 2028 (USD Million)
Table 115. Asia Pacific: Dermatology OTC Medications Market, by Dermatitis Indication - Revenue and Forecast to 2028 (USD Million)
Table 116. Asia Pacific: Dermatology OTC Medications Market, by Fungal Diseases Indication - Revenue and Forecast to 2028 (USD Million)
Table 117. Asia Pacific: Dermatology OTC Medications Market, by Psoriasis Indication - Revenue and Forecast to 2028 (USD Million)
Table 118. Asia Pacific: Dermatology OTC Medications Market, by Warts Indication - Revenue and Forecast to 2028 (USD Million)
Table 119. Asia Pacific: Dermatology OTC Medications Market, By Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 120. Asia Pacific: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 121. China: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 122. China: Dermatology OTC Medications Market, By Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 123. China: Dermatology OTC Medications Market, By Indication - Revenue and Forecast to 2028 (USD Million)
Table 124. China: Dermatology OTC Medications Market, by Acne Indication - Revenue and Forecast to 2028 (USD Million)
Table 125. China: Dermatology OTC Medications Market, by Dermatitis Indication - Revenue and Forecast to 2028 (USD Million)
Table 126. China: Dermatology OTC Medications Market, by Fungal Diseases Indication - Revenue and Forecast to 2028 (USD Million)
Table 127. China: Dermatology OTC Medications Market, by Psoriasis Indication - Revenue and Forecast to 2028 (USD Million)
Table 128. China: Dermatology OTC Medications Market, by Warts Indication - Revenue and Forecast to 2028 (USD Million)
Table 129. China: Dermatology OTC Medications Market, By Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 130. China: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 131. Japan: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 132. Japan: Dermatology OTC Medications Market, By Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 133. Japan: Dermatology OTC Medications Market, By Indication - Revenue and Forecast to 2028 (USD Million)
Table 134. Japan: Dermatology OTC Medications Market, by Acne Indication - Revenue and Forecast to 2028 (USD Million)
Table 135. Japan: Dermatology OTC Medications Market, by Dermatitis Indication - Revenue and Forecast to 2028 (USD Million)
Table 136. Japan: Dermatology OTC Medications Market, by Fungal Diseases Indication - Revenue and Forecast to 2028 (USD Million)
Table 137. Japan: Dermatology OTC Medications Market, by Psoriasis Indication - Revenue and Forecast to 2028 (USD Million)
Table 138. Japan: Dermatology OTC Medications Market, by Warts Indication - Revenue and Forecast to 2028 (USD Million)
Table 139. Japan: Dermatology OTC Medications Market, By Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 140. Japan: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 141. India: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 142. India: Dermatology OTC Medications Market, By Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 143. India: Dermatology OTC Medications Market, By Indication - Revenue and Forecast to 2028 (USD Million)
Table 144. India: Dermatology OTC Medications Market, by Acne Indication - Revenue and Forecast to 2028 (USD Million)
Table 145. India: Dermatology OTC Medications Market, by Dermatitis Indication - Revenue and Forecast to 2028 (USD Million)
Table 146. India: Dermatology OTC Medications Market, by Fungal Diseases Indication - Revenue and Forecast to 2028 (USD Million)
Table 147. India: Dermatology OTC Medications Market, by Psoriasis Indication - Revenue and Forecast to 2028 (USD Million)
Table 148. India: Dermatology OTC Medications Market, by Warts Indication - Revenue and Forecast to 2028 (USD Million)
Table 149. India: Dermatology OTC Medications Market, By Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 150. India: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 151. Australia: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 152. Australia: Dermatology OTC Medications Market, By Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 153. Australia: Dermatology OTC Medications Market, By Indication - Revenue and Forecast to 2028 (USD Million)
Table 154. Australia: Dermatology OTC Medications Market, by Acne Indication - Revenue and Forecast to 2028 (USD Million)
Table 155. Australia: Dermatology OTC Medications Market, by Dermatitis Indication - Revenue and Forecast to 2028 (USD Million)
Table 156. Australia: Dermatology OTC Medications Market, by Fungal Diseases Indication - Revenue and Forecast to 2028 (USD Million)
Table 157. Australia: Dermatology OTC Medications Market, by Psoriasis Indication - Revenue and Forecast to 2028 (USD Million)
Table 158. Australia: Dermatology OTC Medications Market, by Warts Indication - Revenue and Forecast to 2028 (USD Million)
Table 159. Australia: Dermatology OTC Medications Market, By Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 160. Australia: Dermatology OTC Medications Market, by Offline Distribution - Revenue and Forecast to 2028 (USD Million)
Table 161. South Korea: Dermatology OTC Medications Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 162. South Korea: Dermatology OTC Medications Market, By Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 163. South Korea: Dermatology OTC Medications Market, By Indication - Revenue and Forecast to 2028 (USD Million)
Table 164. South Korea: Dermatology OTC Medications Market, by Acne Indication - Revenue and Forecast to 2028 (USD Million)
Table 165. South Korea: Dermatology OTC Medications Market, by Dermatitis Indication - Revenue and Forecast to 2028 (USD Million)
Table 166. South Korea: Dermatology OTC Medications Market, by Fungal Diseases Indication - Revenue and Forecast to 2028 (USD Million)
Table 167. South Korea: Dermatology OTC Medications Market, by Psoriasis Indication - Revenue and Forecast to 2028 (USD Million)
Table 168. South Korea: Dermatology OTC Medications Market, by Warts Indication - Revenue and Forecast to 2028 (USD Million)
Table 169. South Korea: Dermatology OTC Medications Market, By Distribution Channel - Revenue and Forecast to 2028 (USD Million)
List of Figures
Figure 1. Dermatology OTC Medications Market Segmentation
Figure 2. Dermatology OTC Medications Market, By Region
Figure 3. Global Dermatology OTC Medications Market Overview
Figure 4. Creams and Ointments Segment Held Largest Share of Product Type Segment in Dermatology OTC Medications Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Dermatology OTC Medications Market, by Geography (US$ Million)
Figure 7. Global Dermatology OTC Medications Market- Leading Country Markets (US$ Million)
Figure 8. Global Dermatology OTC Medications Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints
Figure 16. Global Dermatology OTC Medications Market- Revenue Forecast and Analysis - 2021 - 2028
Figure 17. Global Dermatology OTC Medications Market - By Geography Forecast and Analysis - 2021 - 2028
Figure 18. Market Positioning of Key Players in Global Dermatology OTC Medications Market
Figure 19. Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)
Figure 20. Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ million)
Figure 21. Gels Market Revenue and Forecasts to 2028 (US$ million)
Figure 22. Creams and Ointments Market Revenue and Forecasts to 2028 (US$ million)
Figure 23. Others Market Revenue and Forecasts to 2028 (US$ million)
Figure 24. Dermatology OTC Medications market Share, by Route of Administration, 2021 and 2028 (%)
Figure 25. Topical: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 26. Oral: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 27. Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)
Figure 28. Dermatitis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 29. Atopic Dermatitis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 30. Contact Dermatitis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 32. Acne: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 33. Non-Inflammatory Acne: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 34. Inflammatory Acne: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 35. Psoriasis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 36. Plaque Psoriasis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 37. Guttate Psoriasis: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 38. Others: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 39. Skin Bleaching: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 40. Fungal Disease: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 41. Athlete's Foot: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 42. Ringworm: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 43. Fungal Nail Infections: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 44. Others: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 45. Warts: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 46. Common Warts: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 47. Flat Warts: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 48. Others: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 49. Others: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 50. Dermatology OTC Medications market Share, by Distribution Channel, 2021 and 2028 (%)
Figure 51. Online Distribution: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 52. Offline Distribution: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 53. Retail and Hospital Pharmacies: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 54. Super and Hyper Markets: Dermatology OTC Medications Market- Revenue and Forecast to 2028 (US$ Million)
Figure 55. North America: Dermatology OTC Medications Market, by Key Country - Revenue (2021) (USD Million)
Figure 56. North America: Dermatology OTC Medications Market Revenue and Forecast to 2028 (USD Million)
Figure 57. North America Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)
Figure 58. US: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 59. Canada: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 60. Mexico: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 61. Europe: Dermatology OTC Medications Market, by Key Country - Revenue (2021) (USD Million)
Figure 62. Europe: Dermatology OTC Medications Market Revenue and Forecast to 2028 (USD Million)
Figure 63. Europe: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)
Figure 64. Germany: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 65. France: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 66. UK: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 67. Italy: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 68. Spain: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 69. Rest of Europe: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 70. Asia Pacific: Dermatology OTC Medications Market, by Key Country - Revenue (2021) (USD Million)
Figure 71. Asia Pacific Dermatology OTC Medications Market Revenue and Forecast to 2028 (USD Million)
Figure 72. Asia Pacific: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)
Figure 73. China: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 74. Japan: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 75. India: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 76. Australia: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 77. South Korea: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 78. Rest of Asia Pacific: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 79. Middle East & Africa Dermatology OTC Medications Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 80. Middle East & Africa Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 81. Middle East & Africa Dermatology OTC Medications Market Revenue and Forecasts to 2028, By Country (%)
Figure 82. UAE: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 83. Saudi Arabia: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 84. South Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 85. Rest of Middle East and Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 86. South & Central America: Dermatology OTC Medications Market, by Key Country - Revenue (2021) (USD Million)
Figure 87. North America: Dermatology OTC Medications Market Revenue and Forecast to 2028 (USD Million)
Figure 88. South & Central America: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)
Figure 89. US: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 90. Argentina: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 91. Rest of South & Central America: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)
Figure 92. Impact of COVID-19 Pandemic in North American Country Markets
Figure 93. Impact of COVID-19 Pandemic in European Country Markets
Figure 94. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 95. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 96. Impact Of COVID-19 Pandemic In South & Central America Market
Figure 97. Growth Strategies in the Dermatology OTC Medications Market , 2021-2028

Executive Summary

The dermatology OTC medications market is expected to grow from US$ 15,456.63 million in 2021 to US$ 21,313.40 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028.

The high prevalence of skin problems and rising income of middle-class population are expected to boost the global market growth. However, the inappropriate use of OTC medications is restraining the growth of market.

The COVID-19 pandemic has been adversely affecting several businesses across global. The supply chain disruptions and the huge demand for efficient treatments of COVID-19 have critically impacted the healthcare research industry in China. Prohibitive measures have been taken to resist the spread of the COVID-19 pandemic. The pandemic is expected to impact the dermatology OTC medications market significantly. For instance, India’s manufacturers rely heavily on imports of their APIs from China. The lockdown has slowed the production of APIs, resulting in less availability and higher costs for the materials required for the products. Owing to the high demand for essential OTC drugs, the government has restricted the export of a few essential medicines. Due to the countrywide lockdown, the traditional supply chain of OTC drugs is facing several challenges. Many of these drugs are not available. Even after the specific guidelines and support of the state government to transport the essential OTC drugs, many retail pharmacies are experiencing a shortage of stock. On the other hand, the online purchase of OTC drugs has increased.

Most of the population agreed that fear of contracting SARS-CoV-2 would be a standalone factor for not undergoing any skin disease treatment during the COVID-19 pandemic in the country. This has resulted in a drastic drop in demand for dermatological treatment. On the other hand, a cross-sectional study conducted by Al Saud et al., published in Plastic and Reconstructive Surgery Global Open Journal, in September 2020, reveals that over two-thirds (~69.5%) of OTC dermatology drugs indicated that the COVID-19 pandemic had negatively affected practices in Saudi Arabia. For example, surgeons in private practices were affected more significantly than the public sector due to fear and future uncertainty, leading to surge in utilization of different technical means for maintaining such a high patient pool.

As per European Union, the middle-class population is expected to reach 5.3 billion by 2030, and the Asian population of middle-class people is likely to be at the forefront. According to the World Bank Group, by 2030, China and India are expected to represent ~66% of the global middle-class population and ~59% of middle-class consumption. With significant changes in consumer behavior and consumption patterns, the middle-class expansion will drive global economic development. In addition, the US Bureau of Labor Statistics stated that disposable income in the US increased from US$ 10,036.9 billion in 2006 to US$ 13,968.6 billion in 2016; it is further expected to reach US$ 21,178.2 billion by 2026. Increased disposable incomes and better after-care treatment have led to the growing adoption of dermatology OTC medications to treat skin conditions. Thus, a surge in the adoption rate of OTC medications supports the growth of the dermatology OTC medications market.

The approval is likely to enables the company to sell these products in the global dermatology OTC medications market. Similarly, the key companies are focusing on strategic initiatives such as mergers, acquisitions, new product development, and geographical expansions. For instance, in July 2016, Galderma received FDA approval for Differin Gel 0.1 percent (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne, in July 2016. Differin Gel 0.1 percent is licensed for usage in people aged 12 and up.

The high prevalence of the skin disease support the growth of the dermatology OTC medications market. Acne affected 5.6 million Canadians, or ~20% of the population, according to the Canadian Dermatology Association in 2021. Similarly, ~80% of acne patients are aged between 12 and 24. Acne affects ~90% of teenagers and 20-30% of adults aged from 20 to 40. Similarly, as per a study published in the journal Actas Dermo-Sifiliográficas in 2019, the prevalence of psoriasis in France was 5.2% of the entire French population. Moreover, according to 2020 US census data, ~7.55 million US individuals are suffering from psoriasis. The prevalence of psoriasis was similar in men and women, with 3.2% in women and 2.8% in men.

The rising healthcare expenditure supports the growth of the dermatology OTC medications market during the forecast period. Pharmaceutical spending includes prescription medications and self-medication, also known as over-the-counter (OTC) items. In 2019, pharmaceutical products spending accounted for 14.3% and 11.9% of Germany's and France’s total healthcare expenditure, respectively.

Indication-Based Insights
The dermatology OTC medications market is segmented into product type, route of administration, indication, and distribution channel. Based on indication, the global market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment held the largest share of the dermatology OTC medications market in 2021; it is estimated to register the highest CAGR in the dermatology OTC medications market during the forecast period.

The Food and Drug Administration, the World Health Organization, the European Commission, the American Academy of Dermatology, the National Center for Biotechnology Information, the Canadian Skin Patient Alliance, the Skin Science Foundation, the European Society for Dermatological Research, the Economic Co-operation and Development, and the Canadian Dermatology Association are among the primary and secondary sources referred to while preparing the report on the dermatology OTC medications market.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bausch Health Companies Inc.
  • Perrig- Company plc
  • Bayer AG
  • Viatris Inc.
  • Johnson and Johnson Services, Inc.
  • Le- Pharma A/S
  • GlaxoSmithKline plc.
  • Galderma
  • Dr. Reddy's Laboratories
  • Acella Pharmaceuticals, LLC